Literature DB >> 19527407

A case of advanced ovarian cancer upstaged on the bases of pleural washing cytology.

Yukari Kobayashi1, Fumitoshi Terauchi, Hirotaka Nishi, Atsuya Fujitou, Hiroe Itou, Keiichi Isaka.   

Abstract

We encountered a case of ovarian cancer that had positive pleural washing cytology diagnosed by thoracoscopy. A 65-year-old woman was referred to our hospital with a sensation of abdominal fullness. A whole-body examination revealed a solid tumor of the ovary and accumulation of ascites. Neither pleural effusion nor lung metastasis was found at the time. Laparotomy showed extensive dissemination and we classified the stage as IIIc. As the diaphragm was thickened with dissemination, we tried to strip the diaphragm and used thoracoscopy to identify the thoracic area. No tumor or pleural effusion was detected. We performed pleural biopsy and pleural washing cytology. Finally, malignant cells were found in the pleural washing cytology. Pathological findings showed serous papillary adenocarcinoma of the ovary in this stage IV case. We suggest in this report that thoracoscopy is a useful method for making the correct surgical staging.

Entities:  

Mesh:

Year:  2009        PMID: 19527407     DOI: 10.1111/j.1447-0756.2008.00967.x

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  2 in total

1.  Diagnosis of ovarian cancers using thoracoscopy: Three case reports and review of the literature.

Authors:  Makoto Nakao; Tetsuya Oguri; Mikinori Miyazaki; Takehiro Uemura; Osamu Takakuwa; Eiji Kunii; Hirotsugu Ohkubo; Ken Maeno; Shigeki Sato
Journal:  Exp Ther Med       Date:  2012-04-11       Impact factor: 2.447

2.  Does VEGF facilitate local tumor growth and spread into the abdominal cavity by suppressing endothelial cell adhesion, thus increasing vascular peritoneal permeability followed by ascites production in ovarian cancer?

Authors:  Inga Bekes; Thomas W P Friedl; Tanja Köhler; Volker Möbus; Wolfgang Janni; Achim Wöckel; Christine Wulff
Journal:  Mol Cancer       Date:  2016-02-12       Impact factor: 27.401

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.